false
Catalog
Pulmonary Hypertension: Expert Didactics and Discu ...
CHEST 2024 PH Masterclass Jean Elwing 100524
CHEST 2024 PH Masterclass Jean Elwing 100524
Back to course
Pdf Summary
The CHEST 2024 Pulmonary Hypertension Master Class focuses on understanding pulmonary arterial hypertension (PAH), its pathophysiology, and treatment algorithms. The session is led by experts such as Jean M. Elwing and Namita Sood and covers various essential topics including the pathophysiology of PAH, diagnostic assessments, and treatment strategies.<br /><br />Key insights from the session include:<br /><br />1. **Pathophysiology of PAH**: PAH involves complex mechanisms such as dysregulation of growth factors, genetic predispositions, cytokine alterations, and inflammation. Despite different triggers, Group I PAH patients experience similar pathologic changes, enabling a standardized treatment algorithm, as per option D in a pre-course assessment question.<br /><br />2. **Recent Developments in Pathobiology**: Recent shifts in understanding emphasize structural changes caused by excessive vascular cell growth and inflammation, involving growth factors, cytokines, and other signaling pathways.<br /><br />3. **Diagnosis**: Hemodynamic definitions refine PAH criteria, guiding diagnostic assessments like echocardiography and right heart catheterization. Case studies illustrate diagnosis with symptoms like dyspnea, murmur, and pathologic findings like right ventricular dilatation.<br /><br />4. **Treatment Guidelines (2022 ESC/ERS)**: The guidelines recommend a comprehensive assessment and stratification of risk using a 3-strata model, followed by initiation of medical therapies such as ERA/PDE5I. Reevaluation occurs in three months, aiming for risk reduction.<br /><br />The course further highlights diagnostic tests, including autoimmune and HIV assessments, lung scans, and functional tests. It emphasizes understanding the current guidelines in echocardiographic evaluation and risk stratification to guide treatment choice effectively. Overall, comprehensive diagnostic work-up and risk-stratified treatment align with the goal of improving long-term outcomes in PAH management.
Keywords
Pulmonary Hypertension
PH
PAH
Pathophysiology
Treatment Algorithms
Jean M. Elwing
Namita Sood
Diagnosis
ESC/ERS Guidelines
Risk Stratification
Echocardiography
Pulmonary Hypertension
PH
©
|
American College of Chest Physicians
®
×
Please select your language
1
English